Comments: NJ A2544 | 2022-2023 | Regular Session
Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2022-02-14 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A2544 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2022-02-14 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A2544 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A2544 at this time. |